Tonometry in all patients is the best way to prevent blindness

Article

It is more cost-effective to perform routine tonometry in all initial ophthalmic patients than in none at all or in just high-risk glaucoma patients, according to a paper published in the March 2008 issue of Eye.

It is more cost-effective to perform routine tonometry in all initial ophthalmic patients than in none at all or in just high-risk glaucoma patients, according to a paper published in the March 2008 issue of Eye.

Using the A. Markov cost-effectiveness simulation model, A. Peeters and colleagues at Maastricht University Hospital, the Netherlands, analyzed and compared three case-finding strategies, measuring cost, proportion of patients becoming blind and years of blindness. The aim of the study was to determine the most cost-effective route for an ophthalmologist to detect and treat ocular hypertension (OH) and primary open-angle glaucoma (POAG) early in order to prevent blindness.

In the study, all patients underwent ophthalmoscopy, but tonometry was routinely performed to: (1) all initial patients, (2) high-risk patients only, or (3) no one. The population characteristics were based on data of 1000 initial patients, and transition probabilities were taken from the literature. The time-horizon of the model was 20 years, using an annual discount rate of 4%.

The researchers found that the costliest strategy - performing tonometry on all initial patients - led to least blindness. The incremental cost-effectiveness ratio, which shows extra costs per year of vision saved in comparison to the cheapest strategy (performing tonometry on no one), was found to be lower for performing tonometry on all initial patients than for performing it solely on high-risk patients. According to the study, it amounts to €1707, not including extra costs due to blindness (such as those associated with the use of disability facilities). When such costs exceed €1707 per patient per year, which is most likely, the first strategy (of performing tonometry on all initial patients) becomes cost saving.

From these results, the study concluded that the most cost-effective method of preventing blindness due to glaucoma is to routinely perform tonometry for all initial ophthalmic patients.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.